Migraine and Body Composition
1 other identifier
observational
300
1 country
1
Brief Summary
This research is being done to look at the association between migraine and obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 31, 2012
CompletedFirst Posted
Study publicly available on registry
November 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedJanuary 28, 2016
January 1, 2016
3.5 years
October 31, 2012
January 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
association between migraine and obesity - evaluate serum adipokine levels
The first aim of the proposed research is to evaluate serum adipokine levels in a clinical cohort of obese and non-obese episodic and chronic migraineurs and examine their utility as markers of the presence or absence of migraine and their relationship to headache frequency.
5 years
Secondary Outcomes (1)
association between migraine and obesity -evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT)
five years
Study Arms (3)
Episodic migraineurs
Those with migraines \>2 and \< 12 times per month.
Chronic migraineurs
Those with migraines greater than 14 days per month.
Controls
Those without headaches other than occasional hangover, cold, flu headaches.
Eligibility Criteria
Premenopausal Caucasian women ages 18-55 years with or without migraine.
You may qualify if:
- Premenopausal women (18-55 years)
- Normal weight (BMI = 18.5 - 24.9) or obese (BMI ≥ 30)
- Diagnosis of episodic or chronic migraine or pain free control
You may not qualify if:
- Evidence of pain disorder other than migraine (e.g. irritable bowel syndrome)
- Chronic conditions known to alter risk or pattern of migraine (e.g. hypothyroidism)
- Illnesses that may affect adipokine levels (e.g. diabetes)
- Clinically relevant abnormal glucose/cholesterol levels
- Pregnant women
- Potential participants who are unable to undergo MRI based on standard screening questionnaire (those with brain aneurysm or surgical clips, certain types of artificial heart valves, heart defibrillator or pacemaker, cochlear implants, eye implants, blood vessel coil, recently placed artificial joints, certain types of vascular stents, history of bullets, pellets, BBs, history of any implanted metal or device or who have worked with sheet metal in the past)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Johns Hopkins Bayview Headache Center
Baltimore, Maryland, 21224, United States
Biospecimen
serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara L Peterlin, DO
Johns Hopkins University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Headache Research, Johns Hopkins Bayview
Study Record Dates
First Submitted
October 31, 2012
First Posted
November 2, 2012
Study Start
April 1, 2012
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
January 28, 2016
Record last verified: 2016-01